GSK plc GSK
NYSE GSK
$50.40 -0.01 (-0.02%)
As of: Nov 6, 2026 · 2:19 PM EST

Gsk (GSK) Goodwill impairment charges (2016 - 2017)

Updated

Gsk's Goodwill impairment charges came in at -$228.36 million for the quarter ended Dec 31, 2017, compared with -$19.89 million a year earlier.

Analysis

Gsk (GSK) Goodwill impairment charges (2016 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,218.90 Bn 1,192.51 Bn 20.46 Bn
2 Johnson & Johnson 663.12 Bn 582.98 Bn 17.30 Bn
3 AbbVie 513.57 Bn 481.58 Bn 13.12 Bn
4 Merck 362.15 Bn 325.10 Bn 13.19 Bn
5 Novartis Ag 314.74 Bn 287.98 Bn -
6 Astrazeneca 288.39 Bn 262.28 Bn 13.26 Bn
7 Amgen 249.05 Bn 200.70 Bn 7.58 Bn
8 Gilead Sciences 208.84 Bn 183.95 Bn 6.73 Bn
9 Pfizer 167.21 Bn 114.57 Bn 12.56 Bn
10 Gsk 102.12 Bn 84.96 Bn 8.73 Bn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -228.36 Mn
Dec 31, 2016 -19.89 Mn
API Access

Gsk Goodwill impairment charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=goodwill-impairment-charges&ticker=GSK&period=max&api_key=YOUR_API_KEY